Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Precancerous Conditions 2Neoplasms 2Weight Loss 1Uterine Cervical Neoplasms 1Radiation Injuries 1Psoriasis 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Fatigue 1Esophageal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Blood Specimen Collection 15Exercise 11Standard of Care 9Behavior Therapy 8Surveys and Questionnaires 7Palliative Care 7Carboplatin 7Methods 6Early Intervention, Educational 6Surgical Procedures, Operative 5Practice Guidelines as Topic 5Paclitaxel 5Interviews as Topic 5Educational Status 5Diet Therapy 5Specimen Handling 4Salpingectomy 4Hyperthermic Intraperitoneal Chemotherapy 4Genetic Testing 4Genetic Counseling 4Drug Therapy 4Counseling 4Yoga 3Psychiatric Rehabilitation 3Music Therapy 3Magnetic Resonance Spectroscopy 3Laparoscopy 3Diathermy 3Cytoreduction Surgical Procedures 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Ovarian Neoplasms × Fatty Acids, Omega-3 × Clear all
NCT01821833 2022-10-05

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

New Mexico Cancer Research Alliance

Phase NA Completed
60 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pain, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡